A UK-based solicitor blogging about defending professionals and regulatory law, mainly in the healthcare sector
Each month I prepare a note of the most interesting or important regulatory developments in community pharmacy over the preceding month(s). October 2022 found us talking about the following: We have a new Secretary of State…
Each month I prepare a note of the most interesting or important regulatory developments in community pharmacy over the preceding month. During September 2022, these were: The National Health Service (Pharmaceutical and Local Pharmaceutical Services)…
Each month I prepare a note of the most interesting or important regulatory developments in community pharmacy over the preceding month. During August 2022, my team and I found ourselves talking about the following with…
Each month I prepare a note of the most interesting or important regulatory developments in community pharmacy over the preceding month. During July 2022, these were: A new Secretary of State for Health and Social Care was appointed…
Each month I prepare a note of the most interesting or important regulatory developments in community pharmacy over the preceding month. During June 2022, my team and I found ourselves talking about the following: The…
Chemist+Druggist recently asked me to comment on an incident involving inappropriate delivery of Boots medication by a Deliveroo driver. The article below appeared in Chemist+Druggist on 30 June 2022: Boots has vowed to investigate…
Each month I prepare a note of the most interesting or important regulatory developments in community pharmacy over the preceding month. During May 2022, my team and I found ourselves talking about the following: Back…
Every month I send clients a note of the most interesting or important regulatory developments in community pharmacy over the preceding month. During April 2022, these were: The Pharmacy Representation Review Steering Group’s proposals on the…
Every month I prepare a note of the most interesting or important regulatory developments in community pharmacy over the preceding month.
Every month I prepare a note of the most interesting or important regulatory developments in community pharmacy over the preceding month. In January 2022, this included the following: The National Health Service (Pharmaceutical and Local…
